News

Showing posts for — Category: Media and Publications

05.22.18

EyeGate technology featured in a Journal of Cataract and Refractive Surgery article

Hyaluronic acid (HA) is a key molecule identified for its wound-healing capacity in dermal and ocular injuries, however it is quickly degraded and cleared by the body limiting its effectiveness...
05.22.18

ScienceDirect: “Treatment of corneal chemical alkali burns with a crosslinked hyaluronic acid film”

The severe and caustic nature of alkali chemical burns affecting the eye often leads to permanent ocular injury and resulting vision loss.  Treatment options are limited, particularly as the topical...
05.22.18

Dr. Paul Karpecki’s article in Ocular Surface Review, “HA: No Laughing Matter”

In this article, Dr. Paul Karpecki takes a closer look at the various hyaluronic acid (HA)-based products optometrists currently have access to and the future role of HA-based therapies in...
05.22.18

EyeGate Poster on Crosslinked Hyaluronic Acid (CMHA-S), Ocular Bandage Gel-based Delivery of Small Molecules

Corneal ulcers are an ocular emergency and a leading cause of blindness globally. The treatment regimen usually requires hourly (or in some cases, even more frequent) round-the-clock administration of topical...
02.12.18

BioWorld Today, February 6, 2018, Eyegate combo candidate foiled by placebo performance in cataract patients

Click here to download the full article
09.08.15

The Wall Street Transcript Interview with EyeGate CEO, Stephen From

Click here for the complete article.